Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

33.89
-0.4700-1.37%
Post-market: 33.920.0300+0.09%19:59 EDT
Volume:1.50M
Turnover:51.30M
Market Cap:3.95B
PE:-7.26
High:34.98
Open:34.79
Low:33.47
Close:34.36
52wk High:43.15
52wk Low:22.96
Shares:116.65M
Float Shares:110.00M
Volume Ratio:0.91
T/O Rate:1.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6676
EPS(LYR):-3.1920
ROE:-88.85%
ROA:-51.86%
PB:9.68
PE(LYR):-10.62

Loading ...

Viking Therapeutics Inc Expected to Post a Loss of $1.25 a Share - Earnings Preview

Reuters
·
Jul 28

Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), Summit Therapeutics (SMMT) and Progyny (PGNY)

TIPRANKS
·
Jul 24

Viking Therapeutics Appoints Dorothy Gemmell to Board of Directors

THOMSON REUTERS
·
Jul 23

Viking Therapeutics to Report Q2 Results After Market Close, Host Conference Call

Reuters
·
Jul 23

Viking Therapeutics (VKTX) Could Be 61% Undervalued As It Starts VK3019 Trial

Simply Wall St.
·
Jul 18

VKTX: Buy Rating Backed by VK2735’s Potential to Transform Obesity Maintenance Therapy Ahead of Key Phase I Data

TIPRANKS
·
Jul 17

Viking Therapeutics Posts Corporate Presentation Highlighting Vk2735 Obesity Drug Program Pipeline

Reuters
·
Jul 15

Does Viking Therapeutics (VKTX) Expanding Into Dual-Agonist Obesity Drugs Reframe Its Long-Term Pipeline Strategy?

Simply Wall St.
·
Jul 10

Movement Alert|Viking Therapeutics Rises 8.68% in Regular Trading, Phase 1 Clinical Trial of Novel Weight Loss Drug VK3019 Boosts Market Sentiment

Market Focus
·
Jul 08

Race to Launch Weight-loss Pills Heats up as Smaller Players Advance

Reuters
·
Jul 08

Trump’s FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?

Macro World​
·
Jul 06

Cantor Fitzgerald Remains a Buy on Viking Therapeutics (VKTX)

TIPRANKS
·
Jul 01

Viking Therapeutics call volume above normal and directionally bullish

TIPRANKS
·
Jun 25

Viking Therapeutics on Pace for Highest Close Since November 2025

Dow Jones
·
Jun 25

Analysts Are Bullish on Top Healthcare Stocks: Silexion Therapeutics (SLXN), Viking Therapeutics (VKTX)

TIPRANKS
·
Jun 25

Viking catalysts include VK3019, VK2735 readouts in Q3, says Raymond James

TIPRANKS
·
Jun 24

Viking Therapeutics: Advancing Obesity Pipeline Supports Buy Rating and Unchanged $102 Price Target

TIPRANKS
·
Jun 24

Viking Therapeutics Begins Phase 1 Testing of Investigational Weight Loss Drug

MT Newswires Live
·
Jun 24

Viking Therapeutics begins Phase 1 SAD clinical trial of VK3019

TIPRANKS
·
Jun 24

Viking Therapeutics Says FDA Clears IND for Vk3019 Obesity Drug Trial

Reuters
·
Jun 24